3Ujfalussy I,Koo E.Measurement of disease activity in psoriatic arthritis.Extended report.Z Rheumatol,2003,62:60-65.
4Kaltwassor JP,Nash P,Gladman D,et al.Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis:a multinational,double-blind,randomized,placebo-controlled clinical trial.Arthritis Rheum,2004,50:1939-1950.
5Nash P,Thaci D,Behrenz F,et al.Leflunomide improves psoriasis in patients with psoriatic arthritis:an in-depth analysis of data from the TOPAS study.Dermatology,2006,212:238-249.
6Pipitone N,Kingsley GH,Manso A,et al.Current concepts and new developments in the treatment of psoriatic arthritis.Rheumatology (Oxford),2003,42:1138-1148.
7Scarpa R,Manguso F,Oriente A,et al.Leflunomide in psoriatic polyarthritis.J Clin Rheumatol,2002,8:286-287.
8Cuchacovich M,Soto L.Leflunomide decreases joint erosions and induces reparative changes in a patient with psoriatic arthritis.Ann Rheum Dis,2002,61:942-943.
9Strand V,Cohen S,Schiff M,et al.Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate.Leflunomide Rheumatoid Arthritis Investigators Group.Arch Intern Med,1999,159:2542-2550.
10Antoni C,Dechant C,Hanns-Martin Lorenz PD,et al.Open-label study of infliximab treatment for psoriatic arthritis:clinical and magnetic resonance imaging measurements of reduction of inflammation.Arthritis Rheum,2002,47:506-512.
